You have no items in your shopping cart.
You have no items in your shopping cart.
| Catalog Number | orb1805459 |
|---|---|
| Category | Antibodies |
| Description | Anti-ROR1 Reference Antibodyd antibody and Monomethyl auristatin E (MMAE) used for the study of several solid tumors. |
| Target | ROR1 |
| Clonality | Recombinant |
| Conjugation | MMAE |
| Reactivity | Human |
| Concentration | Batch dependent |
| Buffer/Preservatives | 100 mM Proline/Acetic acid 20mM Arginine pH 5.0 |
| Purity | >95% |
| Purification | Protein A |
| UniProt ID | Q01973 |
| MW | 145.12 kDa |
| Tested applications | ELISA, FA, FACS, In vivo |
| Antibody Type | Recombinant Antibody |
| Expression System | CHO |
| Endotoxins | <0.001 EU/ug |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |

Anti-ROR1 Reference Antibody (zilovertamab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-ROR1 Reference Antibody (zilovertamab vedotin)is more than 98.21% ;determined by SEC-HPLC.

Immobilized human ROR1 His at 2 μg/mL can bind Anti-ROR1 Reference Antibody (zilovertamab vedotin);EC50=0.002833μg/mL.

zilovertamab vedotin inhibited the tumor growth of MDA-MB-231on NSG mice. The result showed significant anti-tumor effects; with an tumor inhibition rate (TGI) of 96.6% at 10 mpk.
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review